BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1484 related articles for article (PubMed ID: 26943133)

  • 1. The diagnostic ability of
    Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
    Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
    Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving diagnostic performance of
    Yang DD; Mirvis E; Goldring J; Patel ARC; Wagner T
    Clin Radiol; 2019 Oct; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of
    Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
    BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K; Kawakami Y; Hiyama A; Sugi K; Okabe K; Matsumoto T; Ueda K; Tanaka N; Matsunaga N
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
    Pak K; Kim K; Kim MH; Eom JS; Lee MK; Cho JS; Kim YS; Kim BS; Kim SJ; Kim IJ
    PLoS One; 2018; 13(2):e0193403. PubMed ID: 29486012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of F-18 FDG PET/CT in differentiating malignant from benign lesions in pneumoconiosis patients.
    Choi EK; Park HL; Yoo IR; Kim SJ; Kim YK
    Eur Radiol; 2020 Jan; 30(1):442-451. PubMed ID: 31338654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X; Guo Y; Qian X
    Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of endobronchial ultrasound-guided transbronchial needle aspiration, 18-fluorodeoxyglucose positron emission tomography/computed tomography, and ultrasonography imaging techniques in the diagnosis of mediastinal and/or hilar malignant, anthracotic, and other benign lymph nodes.
    Korkmaz C; Demirbas S; Vatansev H
    Medicine (Baltimore); 2021 Feb; 100(7):e24728. PubMed ID: 33607816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation Between SUVmax and CT Radiomic Analysis Using Lymph Node Density in PET/CT-Based Lymph Node Staging.
    Giesel FL; Schneider F; Kratochwil C; Rath D; Moltz J; Holland-Letz T; Kauczor HU; Schwartz LH; Haberkorn U; Flechsig P
    J Nucl Med; 2017 Feb; 58(2):282-287. PubMed ID: 27660141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized visual reading of F18-FDG-PET in patients with non-small cell lung cancer scheduled for preoperative thoracic lymph node staging.
    Rogasch JM; Apostolova I; Steffen IG; Steinkrüger FL; Genseke P; Riedel S; Wertzel H; Achenbach HJ; Kalinski T; Schultz M; Schreiber J; Amthauer H; Furth C
    Eur J Radiol; 2016 Aug; 85(8):1345-50. PubMed ID: 27423672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Shigemoto Y; Suga K; Matsunaga N
    Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endobronchial ultrasound-guided transbronchial needle aspiration of hilar and mediastinal lymph nodes detected on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
    Minami D; Takigawa N; Oda N; Ninomiya T; Kubo T; Ohashi K; Sato A; Hotta K; Tabata M; Kaji M; Tanimoto M; Kiura K
    Jpn J Clin Oncol; 2016 Jun; 46(6):529-33. PubMed ID: 27004902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of EBUS-TBNA in addition to [
    Guberina M; Darwiche K; Hautzel H; Ploenes T; Pöttgen C; Guberina N; Herrmann K; Umutlu L; Wetter A; Theegarten D; Aigner C; Eberhardt WEE; Schuler M; Karpf-Wissel R; Stuschke M
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2894-2903. PubMed ID: 33547554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative volumetric CT-histogram analysis in N-staging of 18F-FDG-equivocal patients with lung cancer.
    Flechsig P; Kratochwil C; Schwartz LH; Rath D; Moltz J; Antoch G; Heussel CP; Rieser M; Warth A; Zabeck H; Kauczor HU; Haberkorn U; Giesel FL
    J Nucl Med; 2014 Apr; 55(4):559-64. PubMed ID: 24525209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
    Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
    Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of
    Girard A; Rouanne M; Taconet S; Radulescu C; Neuzillet Y; Girma A; Beaufrere A; Lebret T; Le Stanc E; Grellier JF
    Eur Radiol; 2019 Aug; 29(8):4286-4293. PubMed ID: 30666449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 75.